Table 1.
Variable | N (%) |
---|---|
Age, y (median, IQR) | 55.50 (39.75-65.00) |
Sex (female) | 39 (88.7%) |
Ethnicity | |
White | 35 (79.5%) |
East Asian | 4 (9.1%) |
African | 2 (4.5%) |
Middle East/Aboriginal/Latino | 3 (6.8%) |
Past medical history of any allergic reaction | 44 (100%) |
Drug allergy label | 44 (100%) |
Food allergy label | 15 (34.1%) |
Allergic rhinitis | 15 (34.1%) |
Asthma | 9 (20.5%) |
Atopic dermatitis | 2 (4.5%) |
Idiopathic urticaria or angioedema | 8 (18.2%) |
History of anaphylaxis | 12 (27.3%) |
Charlson Comorbidity Index score | |
Mild1,2 | 22 (50%) |
Moderate3,4 | 12 (27.2%) |
Severe (≥5) | 10 (22.7%) |
Current medications | |
Beta-blockers | 3 (6.8%) |
ACE inhibitors | 4 (9.1%) |
Angiotensin-receptor blockers | 4 (9.1%) |
Immunosuppressive medications | 5 (11.4%) |
Prednisone | 2 (4.5%) |
Anticoagulants | 2 (4.5%) |
Abbreviations: ACE, angiotensin-converting enzyme; IQR, interquartile range.